These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21787824)

  • 1. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
    Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
    Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
    Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
    Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
    Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Hemphill A
    Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis.
    Pastor-Fernández I; Arranz-Solís D; Regidor-Cerrillo J; Álvarez-García G; Hemphill A; García-Culebras A; Cuevas-Martín C; Ortega-Mora LM
    Vet Parasitol; 2015 Jan; 207(3-4):203-15. PubMed ID: 25579396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
    Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
    Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 78 kDa host cell invasion protein of Neospora caninum as a potential vaccine candidate.
    Lv Q; Xing S; Gong P; Chang L; Bian Z; Wang L; Zhang X; Li J
    Exp Parasitol; 2015 Jan; 148():56-65. PubMed ID: 25448355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice.
    Mansilla FC; Franco-Mahecha OL; Lavoria MÁ; Moore DP; Giraldez AN; Iglesias ME; Wilda M; Capozzo AV
    Vaccine; 2012 Feb; 30(6):1124-31. PubMed ID: 22178728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice.
    Aguado-Martínez A; Alvarez-García G; Fernández-García A; Risco-Castillo V; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2009 Dec; 27(52):7331-8. PubMed ID: 19782735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
    Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
    Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
    Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
    Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.